[This retracts the article DOI: 10.7759/cureus.60827.].
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11882123 | PMC |
http://dx.doi.org/10.7759/cureus.r169 | DOI Listing |
Cureus
March 2025
Department of Radiodiagnosis, Dr. D. Y. Patil Medical College, Hospital & Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to Be University), Pune, IND.
[This retracts the article DOI: 10.7759/cureus.60827.
View Article and Find Full Text PDFEur J Radiol
February 2025
Department of Radiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Electronic address:
Background: Pseudocirrhosis that may be triggered by the treatment of breast cancer liver metastasis often begins insidiously and progresses rapidly. This complicates the accurate assessment of tumor growth or regression. Without timely intervention, patients are at significant risk of death due to acute liver failure or bleeding from ruptured varices.
View Article and Find Full Text PDFJ Cosmet Dermatol
February 2025
Department of Dermatology, Air Force Medical University Air Force Medical Center, Beijing, China.
Background: The ocular adverse reactions caused by the diffusion of BoNT-A injection are self-limiting, with symptoms ameliorating over time. Thyroid-associated ophthalmopathy (TAO) is an autoimmune disease characterized by symptoms such as exophthalmos, diplopia, and eyelid retraction, which may overlap the side effects of BoNT-A injections. It is crucial to consider other ocular diseases when assessing side effects after BoNT-A injection, particularly in patients with a history of thyroid disease.
View Article and Find Full Text PDFNeurosurg Rev
February 2025
Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education & Research, Wardha, India.
Langmuir
March 2025
Department of Chemical Engineering, Indian Institute of Technology, Guwahati 781039, Assam, India.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!